Envoy Medical (COCHW) Debt to Equity (2021 - 2025)

Envoy Medical has disclosed Debt to Equity across 5 years of filings, most recently posting -$0.94 for Q2 2025.

• Debt to Equity for Q2 2025 came in at -$0.94, down 364.03% year-over-year; the trailing twelve-month figure through Jun 2025 was -$0.94 (down 364.03% YoY), and the FY2024 annual result was -$0.5, down 182.89% from the prior year.
• Debt to Equity came in at -$0.94 for Q2 2025 at Envoy Medical, up from -$0.95 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.05 in Q3 2023 to a low of -$0.95 in Q1 2025.
• The 5-year median for Debt to Equity is -$0.19 (2023), against an average of -$0.35.
• Across the five-year window, Debt to Equity sank 1792.0% in 2023 and slumped 182.89% in 2024, its largest moves.
• Envoy Medical's Debt to Equity stood at -$0.0 in 2021, then plunged by 91.17% to -$0.01 in 2022, then tumbled by 1792.0% to -$0.18 in 2023, then plunged by 182.89% to -$0.5 in 2024, then slumped by 88.84% to -$0.94 in 2025.
• The last three Debt to Equity figures came in at -$0.94 (Q2 2025), -$0.95 (Q1 2025), and -$0.5 (Q4 2024), per Business Quant data.